Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 12.65% vs 0.27% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 55.55% vs 126.86% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 37.03% vs 4.19% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -12.64% vs 12.78% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Towa Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 12.65% vs 0.27% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 4.63% vs 15.43% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 55.55% vs 126.86% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 9.90% vs 76.76% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 37.03% vs 4.19% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 12.58% vs 23.25% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is -12.64% vs 12.78% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 37.82% vs 47.33% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






